The measles case definition attributed a death to measles if at least one physician assigned measles as the cause of death or if the respondent reported the deceased child to have a history of …
Child measles mortality rates.
Cross-hatched regions represent campaign states. AN = Andaman and Nicobar Islands. AP = Andhra Pradesh. AR = Arunachal Pradesh. AS = Assam. BR = Bihar. CH = Chandigarh. CG = Chhattisgarh. DD = Daman …
State-level distribution of 1-59 month measles deaths.
Refer to Figure 1 for the definition of measles deaths. Control deaths were selected based on comparability of their pre-intervention trends to trends for measles. For measles in campaign states and …
Child measles, pneumonia, and diarrhoea mortality rates in campaign states.
The measles case definition attributed a death to measles if at least one physician assigned measles as the cause of death or if the respondent reported the deceased child to have a history of …
Child measles mortality rates in campaign states by age and sex.
We present two narrower measles definitions of one or more physician coding and both physician coding of measles. All other control deaths were injuries, non-communicable diseases, or congenital …
Child measles mortality rates by case definition.
Estimates were obtained from the National Family Health Survey and the District Level Household and Facility Survey through 2002 to 2014. Measles vaccination coverage was defined as the percentage …
N = number of observations; n = number of measles deaths. Living in a campaign district was assigned based on the individual’s date of birth and the month when a particular district launched …
We fitted maps using a generalized linear geostatistical model with integrated nested Laplace approximations adjusted for children living in campaign districts and urban/rural residence. * denotes …
Child Characteristics | Campaign States (n = 1,195) | Non-campaign States (n = 443) | ||||
---|---|---|---|---|---|---|
2005–9/2010–13 | 2005–9/2010–13 | |||||
Study Deaths | % | Crude OR (95% CI) | Study Deaths | % | Crude OR (95% CI) | |
Age Groups | ||||||
1 to 11 Months | 374/68 | 36/33 | Ref | 159/63 | 49/48 | Ref |
12 to 59 Months | 627/126 | 64/67 | 1.6 (1.5, 1.9) | 151/70 | 51/52 | 1.3 (1.0, 1.5) |
Sex | ||||||
Male | 415/86 | 41/41 | Ref | 142/54 | 45/43 | Ref |
Female | 586/108 | 59/59 | 1.1 (0.8, 1.6) | 168/79 | 55/57 | 1.2 (0.8, 1.9) |
Residence | ||||||
Urban | 116/30 | 12/14 | Ref | 69/28 | 33/29 | Ref |
Rural | 885/164 | 88/86 | 0.7 (0.5, 1.1) | 241/105 | 67/71 | 1.1 (0.6, 1.8) |
National Health Mission (NHM) | ||||||
Other States | 148/35 | 8/11 | Ref | 211/99 | 77/81 | Ref |
NHM States | 853/159 | 92/89 | 0.8 (0.5, 1.2) | 99/34 | 23/19 | 0.7 (0.4, 1.2) |
Empowered Action Group (EAG) | ||||||
Richer States | 195/46 | 9/11 | Ref | 236/105 | 80/83 | Ref |
Poorer States | 806/148 | 91/89 | 0.8 (0.5, 1.1) | 74/28 | 20/17 | 0.9 (0.5, 1.4) |
Family Reported Child Had History of Measles† | ||||||
Yes | 783/132 | 79/64 | 3.0 (1.7, 5.1) | 235/101 | 76/76 | 0.7 (0.2, 1.8) |
No | 48/24 | 4/13 | Ref | 23/7 | 7/5 | Ref |
Missing | 170/38 | 17/23 | 52/25 | 17/19 | ||
Child Received ≥ 1 Dose of Measles Vaccine‡ | ||||||
Yes | 346/91 | 34/47 | 0.4 (0.3, 0.6) | 144/66 | 48/51 | 0.9 (0.6, 1.5) |
No | 509/75 | 51/38 | Ref | 125/54 | 39/40 | Ref |
Missing | 146/28 | 15/15 | 41/13 | 13/9 | ||
History of Rash | ||||||
Yes | 866/159 | 86/78 | 1.4 (0.9, 2.1) | 275/119 | 87/89 | 1.1 (0.5, 2.2) |
No | 126/32 | 13/21 | Ref | 30/14 | 11/11 | Ref |
Missing | 9/3 | 1/1 | 5/0 | 2/0 | ||
History of Fever | ||||||
Yes | 761/135 | 75/69 | 1.2 (0.8, 1.8) | 214/98 | 72/74 | 0.7 (0.4, 1.2) |
No | 209/46 | 22/24 | Ref | 84/28 | 25/21 | Ref |
Missing | 31/13 | 3/7 | 12/7 | 3/5 |
The measles case definition attributed a death to measles if at least one physician assigned measles as the cause of death or if the respondent reported the deceased child to have a history of measles (using the local language term).
† Respondents were asked whether the child had any skin diseases or rash, followed by whether this was measles using the local term.
‡ Respondents were asked whether the child was immunized and, if so, whether they received an injection for measles using the local term.
Sample characteristics.
Big States in India | AARR (95% CI) |
---|---|
Campaign States | 14.6 (5.3, 23.0) |
Assam | 1.7 (–0.6, 3.9) |
Bihar | 12.2 (–1.5, 24.1) |
Chhattisgarh | 16.9 (1.0, 30.3) |
Gujarat | 13.6 (1.2, 24.4) |
Haryana | 2.8 (–3.3, 8.5) |
Jharkhand | 8.2 (–24.9, 32.4) |
Madhya Pradesh | 19.9 (6.6, 31.3) |
Rajasthan | 16.8 (4.6, 27.3) |
Uttar Pradesh | 18.8 (14.5, 22.8) |
Non-Campaign States | 6.8 (3.8, 9.7) |
Andhra Pradesh | 12.9 (0.3, 24.0) |
Himachal Pradesh | –7.7 (–32.8, 12.7) |
Jammu and Kashmir | 2.6 (–3.4, 8.2) |
Karnataka | 16.2 (7.9, 23.8) |
Maharashtra | –3.3 (–13.8, 6.2) |
Odisha | 6.0 (–0.8, 12.4) |
Punjab | 7.5 (–0.6, 14.9) |
Tamil Nadu | 6.2 (–2.5, 14.2) |
Uttarakhand | 7.9 (–13.1, 25.0) |
West Bengal | 7.5 (2.7, 12.1) |
India (Overall) | 12.2 (4.7, 19.0) |
AARR = average annual rate reduction. States with AARR containing zero in the 95% confidence interval were considered to have no significant change in AARR of measles mortality. In campaign states, the pre-intervention AARR is −4.0% (-42.0%, 24.0%) and the post-intervention AARR is 26.8% (-1.1%, 47.0%). In non-campaign states, the pre-intervention AARR is 1.4% (-18.6%, 18.1%) and the post-intervention AARR is 10.6% (2.5%, 18.1%).
Average annual rate reduction of measles mortality.
Change in slope before campaign launch | Change in slope after campaign launch | Adjusted change in level | Adjusted change in slope | P-value of adjusted change in slope | |
---|---|---|---|---|---|
India | –0.009 (–0.056, 0.038) | –0.125 (–0.251, 0.001) | 0.165 (–0.405, 0.736) | –0.132 (–0.252,–0.011) | 0.034 |
Girls | –0.005 (–0.298, 0.684) | –0.135 (–0.240,–0.031) | 0.204 (–0.291, 0.700) | –0.135 (–0.227,–0.043) | 0.006 |
Boys | –0.014 (–0.071, 0.044) | –0.112 (–0.272, 0.049) | 0.058 (–0.673, 0.788) | –0.125 (–0.278, 0.029) | 0.107 |
12-to-59-months | –0.011 (–0.060, 0.038) | –0.124 (–0.243,–0.024) | 0.148 (–0.288, 0.584) | –0.139 (–0.235,–0.043) | 0.006 |
1-to-11-months | 0.001 (–0.042, 0.044) | –0.129 (–0.296, 0.038) | 0.162 (–0.653, 0.977) | –0.127 (–0.287, 0.032) | 0.113 |
Campaign States | –0.004 (–0.065, 0.056) | –0.157 (–0.320, 0.007) | 0.121 (–0.592, 0.835) | –0.164 (–0.320,–0.008) | 0.040 |
Girls | –0.004 (–0.062, 0.053) | –0.178 (–0.330,–0.025) | 0.256 (–0.362, 0.873) | –0.177 (–0.307,–0.047) | 0.019 |
Boys | –0.002 (–0.083, 0.079) | –0.137 (–0.331, 0.057) | –0.023 (–0.915, 0.870) | –0.150 (–0.336, 0.036) | 0.109 |
12-to-59-months | –0.010 (–0.070, 0.051) | –0.161 (–0.306,–0.016) | 0.166 (–0.432, 0.763) | –0.175 (–0.314,–0.036) | 0.015 |
1-to-11-months | 0.011 (–0.048, 0.069) | –0.152 (–0.361, 0.058) | –0.001 (–0.355, 0.046) | –0.155 (–0.355, 0.046) | 0.125 |
Non-campaign States | –0.027 (–0.041,–0.014) | –0.040 (–0.090, 0.010) | 0.193 (–0.094, 0.481) | –0.037 (–0.088, 0.015) | 0.157 |
Data are ordinary least-squares regression models adjusted for time fixed effects and time interactions. Estimates are given with 95% confidence intervals. Refer to Figure 2 and Table 5 for the description of measles and control deaths definition. Campaign states include: Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Jharkhand, Madhya Pradesh, Manipur, Meghalaya, Nagaland, Rajasthan, Tripura, and Uttar Pradesh. Non-campaign states include all other states and union territories. For India and campaign states, change in slope is adjusted for trends in control conditions of injuries, non-communicable diseases, or congenital anomalies. Control groups are selected based on comparison of pre-intervention trends for each non-measles cause of death to that of measles and selecting those groups who show no significant change in pre-intervention slope. The adjusted change in level represents the difference in the level between measles and control in the six months immediately following campaign launch. The adjusted change in slope is a difference-in-difference slope representing the difference between the treatment and control group's differences in their pre-intervention and post-intervention trends.
Expected 2013 rate per 1,000 live births | Observed 2013 rate per 1,000 live births | Deaths without intervention, 2010–2013 (000 s) | Deaths averted, 2010- 2013 (000s) | Percent averted (%) | |
---|---|---|---|---|---|
India | 1.84 | 0.69 | 73–143 | 41–56 | 39–57% |
Campaign States | 2.77 | 0.76 | 63–111 | 38–44 | 40–60% |
Girls | 3.63 | 0.88 | 31–61 | 16–21 | 34–52% |
Boys | 2.05 | 0.63 | 32–50 | 22–23 | 46–69% |
Non-campaign States | 0.66 | 0.53 | 10–32 | 3–12 | 30–38% |
Data are ordinary least-squares regressions models adjusted for time fixed effects and time interactions. The expected rates were extrapolated by extending the pre-intervention trend to the end of the time series and then applied to the estimated UN live births at 2013 to estimate the potential magnitude of the intervention effects. National estimates are derived from the summation of stratified models. The range represents the upper and lower bounds on the basis of one or more physician coding including family reporting the child to have a history of measles (using the local language term) and only one or more physician coding, respectively.
Disease | ICD-10 code range |
---|---|
Measles | B01, B05 |
Diarrhoea | A00-A09 |
Pneumonia | A37, H65-H68, H70, H71, J00-J06, J09-J18, J20-J22, J32, J36, J85, J86, P23, U04 |
Injuries | S00-S99, T00-T71, T73-T75, T78-T98, V01-V06, V09-V99, W00-W46, W49-W60, W64-W70, W73-W81, W83-W94, W99, X00-X06, X08-X52, X57-X99, Y00-Y36, Y40-Y66, Y69-Y91, Y97, Y98 |
Congenital anomalies | Q00-Q07, Q10-Q18, Q20-Q28, Q30-Q45, Q50-Q56, Q60-Q87, Q89-Q93, Q95, Q96-Q99 |
Non-communicable diseases | C00-C26, C30-C34, C37-C41, C43-C58, C60-C85, C88, C90-C97, D01-D07, D09-D48, D55-D77, D80-D84, D86, D89, E03-E07, E10-E16, E20-E32, E34, E35, E65-E68, E70-E80, E83-E90, F00-F07, F09-F25, F28-F34, F38-F45, F48, F50-F55, F59-F66, F68-F73, F78-F84, F88-F95, F98, F99, G10-G13, G20-G26, G30-G32, G35-G37, G40, G41, G43-G47, G50-G64, G70-G73, G80-G83, G90-G99, H00-H06, H11, H13, H15-H22, H25-H28, H30-H36, H40 H42, H43-H55, H57-H59, H61, H62, H69, H72-H75, H80-H83, H90-H95, I00-I02, I05-I13, I15, I20-I28, I31, I34-I38, I42-I52, I60-I74, I77-I89,I95, I97-I99, J30, J31, J33-J35, J37-J47, J60, J64, J66-J70, J80-J82,J84, J90-J96, J98, J99, K00, K03, K06-K14, K20-K23, K25-K31,K35-K38, K40-K46, K50-K52, K55-K60, K62, K63, K70-K77, K80, K82, K83, K85-K87, K90-K93, L05, L10-L14, L20-L30, L40-L45, L50-L60, L62-L68, L70-L75, L80-L95, L97-L99, M02, M03, M05-M25, M30-M36, M40-M43, M45-M51, M53, M54, M61-M63, M65-M68, M70-M73,M75-M77, M79-M85, M87-M96, M99, N00-N08, N11-N23, N25-N29,N31-N33, N35-N37, N39, N40, N42-N48, N50, N51, N60, N62-N64, N75-N77, N80-N99, P04, P08, P51, P53-P60, P70-P72, P74-P76, P78, P80, P81, P83, P92-P94, R00, R01, R03-R05, R06, R11-R23, R26, R27, R29-R36, R39-R49, R55, R56, R59, R63, R70-R74, R76, R77, R80-R82, R84-R87, R90, R91 |
The measles case definition attributed a death to measles if at least one physician coded measles as the cause of death; or that the living respondent reported the child to have a history of measles (using the local language term. Control deaths were final codes of injury, non-communicable disease, or congenital anomaly.
N = 26,505 | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 |
---|---|---|---|---|---|---|
Level 1 (Individual/Child) | ||||||
12–59 months (v. 1–11 months) | --- | 1.50 (1.34, 1.69) | --- | --- | 1.56 (1.38, 1.75) | 1.48 (1.33, 1.42) |
Female (v. Male) | --- | 1.28 (1.16, 1.42) | --- | --- | 1.28 (1.15, 1.41) | 1.28 (1.15, 1.42) |
Born ≥ 2009 (v. < 2009) | --- | 0.74 (0.66, 0.84) | --- | --- | 0.80 (0.70, 0.91) | 0.80 (0.70, 0.91) |
Rural (v. Urban) | --- | 1.04 (0.89, 1.21) | --- | --- | 1.05 (0.90, 1.22) | 1.04 (0.89, 1.21) |
Antibiotics (v. No) | --- | 1.15 (0.96, 1.38) | --- | --- | 1.14 (0.95, 1.37) | --- |
Missing/Unknown | --- | 0.89 (0.76, 1.04) | --- | --- | 0.88 (0.75, 1.03) | --- |
Received at Least One Measles Vaccine (v. No) | --- | 1.03 (0.91, 1.15) | --- | --- | 1.03 (0.92, 1.16) | --- |
Missing/Unknown | --- | 0.87 (0.73, 1.03) | --- | --- | 0.87 (0.75, 1.03) | --- |
Level 2 (District) | ||||||
Living in Measles Campaign District (v. No) | --- | --- | 0.54 (0.39, 0.75) | --- | 0.57 (0.40, 0.80) | 0.57 (0.40, 0.80) |
Level 3 (State) | ||||||
Measles Vaccination (%) | --- | --- | --- | 0.97 (0.94, 1.00) | 0.96 (0.92, 0.99) | 0.96 (0.92, 0.99) |
Vitamin A Supplementation (%) | --- | --- | --- | 0.99 (0.97, 1.02) | 0.99 (0.97, 1.01) | 0.99 (0.97, 1.01) |
Oral Rehydration Supplementation (%) | --- | --- | --- | 0.97 (0.94, 0.99) | 0.97 (0.94, 0.99) | 0.97 (0.94, 0.99) |
Maternal Literacy (%) | --- | --- | --- | 0.97 (0.94, 0.99) | 0.97 (0.95, 1.00) | 0.97 (0.95, 1.00) |
Diarrhoea Treatment-seeking (%) | --- | --- | --- | 1.00 (0.99, 1.03) | 1.01 (0.98, 1.03) | 1.00 (0.98, 1.03) |
Pneumonia Treatment-seeking (%) | --- | --- | --- | 1.06 (1.02, 1.10) | 1.07 (1.02, 1.11) | 1.07 (1.02, 1.11) |
Measures of Variation | ||||||
Area-level Variance (SE) | ||||||
District | 0.09 (0.03) | 0.14 (0.05) | 0.09 (0.03) | 0.07 (0.03) | 0.07 (0.03) | 0.07 (0.03) |
State | 0.15 (0.06) | 0.09 (0.03) | 0.16 (0.06) | 0.15 (0.06) | 0.15 (0.06) | 0.14 (0.07) |
Median Odds Ratio | ||||||
District | 1.34 | 1.34 | 1.34 | 1.44 | 1.28 | 1.28 |
State | 1.44 | 1.42 | 1.46 | 1.30 | 1.44 | 1.43 |
Intra-class Correlation (%) | ||||||
District | 6.83 | 6.46 | 7.02 | 6.33 | 6.10 | 5.99 |
State | 4.17 | 3.83 | 4.39 | 4.28 | 4.14 | 4.06 |
All models are fitted with random intercepts at the district and state level. Model 1 is a null model containing no predictors in order to assess variance and clustering. Model 2 includes only individual-level characteristics. Models 3 and 4 include only district- and state-level predictors, respectively. Model 5 includes all predictors. Model 6 includes only the relevant predictors from the previous model.